Yadav et al. (2011) observed a significant correlation between TGF-β1 levels and adiposity in humans and rodents, and inhibiting TGF-β1 signalling protected mice from obesity, hepatic steatosis, and diabetes [36]. The gene discussed is TGFB1; the disease is obesity due to melanocortin 4 receptor deficiency.